Business Context and Reporting Period
This Form 8-K was filed by Priveterra Acquisition Corp. on February 10, 2023, following a special stockholder meeting. The filing is not an operating report for AEON Biopharma, Inc.; the source document identifies Priveterra Acquisition Corp. as the registrant.
Priveterra is a special purpose acquisition company that sought to complete a business combination. Stockholders approved an amendment extending the deadline to complete a business combination from February 11, 2023, to August 11, 2023.
Financial Metrics and Capital Structure
- 27,795,918 shares, representing 80.56% of issued and outstanding common stock, were present at the special meeting, constituting a quorum.
- 25,597,728 Class A common shares were redeemed for approximately $10.11 per share.
- Total redemption amount was approximately $258,793,030.08.
- The filing does not provide revenue, profit, cash flow, operating margins, debt, or liquidity balances beyond the disclosed redemption amount.
Material Changes Versus the Prior Comparable Period
- The contractual termination date was extended by six months, from February 11, 2023, to August 11, 2023.
- The redemption of 25,597,728 Class A shares materially reduced the company’s public share count and trust-related capital available for a potential business combination. The filing text does not provide the remaining share count or post-redemption cash balance.
Guidance, Outlook, Risks, and Unusual Items
- The extension provides additional time to consummate a business combination; it does not establish that a transaction will be completed.
- The substantial share redemptions may reduce funds available for a transaction and increase execution and financing risks.
- The adjournment proposal was not presented because the extension proposal received sufficient votes.
- The filing provides no operating guidance, earnings outlook, or management forecast.
Most Important Facts to Verify
- Verify that the intended issuer is Priveterra Acquisition Corp., not AEON Biopharma, Inc.
- Verify the terms and effective date of the charter amendment extending the business-combination deadline to August 11, 2023.
- Verify the final post-redemption share count, trust-account balance, and cash available for a business combination.
- Verify whether Priveterra ultimately completed a business combination before the amended termination date.